Whalesbook
Mixed Results: Strong VNB Growth Amidst APE Decline
Canara HSBC Life Insurance's results for the fourth quarter of fiscal year 2026 showed mixed financial signals. The company posted a robust 48.7% year-over-year increase in its Value of New Business (VNB) to ₹2.1 billion, well above market expectations by 21.4%. This strong performance was primarily driven by substantial growth in the protection segment (+96.1% year-over-year), non-par savings (+43.4%), and annuity products (+24.7%). However, this positive momentum was tempered by a miss in annualized premium equivalent (APE), which declined 29.8% quarter-on-quarter to ₹700 crore, though it grew 12.0% year-on-year. The decline in Unit Linked Insurance Plans (ULIPs) by 31.9% year-over-year was a key factor in the APE shortfall.
Analyst Adjusts Target as Stock Shows Mixed Performance
Brokerage firm Systematix, while maintaining its 'Buy' rating, adjusted its price target downwards to ₹180 from ₹190. This target values the insurer at 1.7 times its estimated embedded value per share for FY28. The stock, trading around ₹136-₹146 in late April 2026, has shown mixed recent performance, with a 1.35% decline in the last month but a 14.96% gain over six months. The market reaction suggests caution over the APE miss, even with the strong VNB growth. Its price-to-earnings (P/E) ratio remains high at around 107-115x. Investors expect this strong VNB growth to lead to sustainable profits.
Peers Show Varied Results, Sector Recovers
Canara HSBC Life's performance differs from some rivals. ICICI Prudential Life reported a 61.95% year-over-year increase in net profit to ₹623.91 crore for Q4 FY26, reaching an all-time quarterly high, achieved despite a sharp drop in revenue. SBI Life saw its net profit decline marginally by 1.09% year-over-year to ₹804.64 crore, despite a 16.02% rise in net premium income. Concerns for SBI Life focused on its deeply negative operating profit before other income. HDFC Life reported a more modest 4% year-over-year profit growth to ₹496 crore, with its VNB margin contracting to 24% from 26.5% a year prior, impacted by Goods and Services Tax (GST) and regulatory changes. However, the broader Indian life insurance sector recovered in FY26, with new business premiums up 15.7% year-over-year, a jump from FY25's 5.1% growth. This was driven by private insurers and strong group insurance sales.
Risks Emerge from APE Miss and Valuation Concerns
Despite impressive VNB growth, the sharp drop in ULIPs and the APE miss pose risks. ULIPs have historically been key profit drivers, so a continued decline could hurt future earnings. The reduced price target from Systematix, even with a 'Buy' rating, suggests a potential re-evaluation of its valuation multiples. While the agency channel is showing early promise, contributing ₹14 crore in APE in less than six months, its ability to compensate for weakness in other areas and boost overall APE growth is yet to be proven. Canara HSBC Life's P/E ratio remains significantly higher than many peers, including SBI Life and HDFC Life, which traded at 76x and 71x respectively. This high valuation requires consistent execution and strong growth across all its business lines to be justified. The company's full-year FY26 VNB margin was 22.4%, which, though improved, trails competitors like SBI Life (27.5%). This suggests achieving the scale needed for its current valuation will be challenging.
Management Focuses on Sustained Growth
Canara HSBC Life's management reported 41% year-over-year VNB growth to ₹627 crore in FY26, achieving a margin of 22.4%. The company plans for continued growth, supported by its bancassurance channel and its growing agency network. Continued growth in protection and savings segments will be crucial to offset the ULIP decline and meet market expectations for its high valuation. Its ability to navigate evolving regulations and competition, especially from larger players with wider distribution, will shape its path in FY27.